Similares a Ersodetug Shows Target Engagement but Misses Primary Endpoints in Phase 3 cHI Study

20 vecinos (text_768) · 20 views · HCPLive · Estados Unidos


★	Ersodetug Shows Target Engagement but Misses Primary Endpoints in Phase 3 cHI Study	HCPLive @hcplivenews	20	Estados Unidos
6	Diabetes Dialogue: Omnipod and AID Advancements at Insulet, With Trang Ly, PhD, MBBS	HCPLive @hcplivenews	4.3K	Estados Unidos	88
11	Retatrutide Provides Substantial Weight Loss in Patients With Obesity or Overweight	HCPLive @hcplivenews	1.1K	Estados Unidos	88
8	Diabetes Dialogue: FDA Approves Afrezza Inhaled Insulin for Pediatric Patients	HCPLive @hcplivenews	683	Estados Unidos	88
9	Diabetes Dialogue: Retatrutide Phase 3 Data Show Major Weight Loss	HCPLive @hcplivenews	533	Estados Unidos	88
3	TRIUMPH-2: Retatrutide Reduces Weight, A1C in Patients With Obesity	HCPLive @hcplivenews	350	Estados Unidos	88
17	The World’s First Dual Glucose-Ketone Monitor Receives Clearance in Europe	HCPLive @hcplivenews	313	Estados Unidos	87
14	Diabetes Dialogue: Tech, Screening, and Care Highlights from ADCES 2026	HCPLive @hcplivenews	224	Estados Unidos	87
1	Diabetes Dialogue: Weekly Insulin Icodec Now Available for Type 2 Diabetes	HCPLive @hcplivenews	206	Estados Unidos	89
19	Functional Cures for T1D: Insulin Independence Through Islet Transplantation	HCPLive @hcplivenews	185	Estados Unidos	87
2	Diabetes Dialogue: CKM Systems, Triple Agonists, and a Sensor Scandal Ahead of ADA	HCPLive @hcplivenews	179	Estados Unidos	88
10	Retatrutide Cuts Weight, Cardiovascular Disease Risk in TRIUMPH-3	HCPLive @hcplivenews	158	Estados Unidos	88
16	Diabetes Dialogue: Tegoprubart and Freedom from Insulin in Type 1 Diabetes	HCPLive @hcplivenews	143	Estados Unidos	87
15	Diabetes Dialogue: CONNECT, TRANSCEND, and TRIUMPH at ADA 2026	HCPLive @hcplivenews	114	Estados Unidos	87
4	Insulin Icodec Dosing Strategies for Type 2 Diabetes	HCPLive @hcplivenews	105	Estados Unidos	88
12	Incretins, Monitors, and Insulin Titration at ADA 2026	HCPLive @hcplivenews	76	Estados Unidos	88
20	METRE-PL Data Shows Severe Metabolic Disease Burden in FPLD Despite Standard Therapy	HCPLive @hcplivenews	57	Estados Unidos	87
5	Diabetes Dialogue: Teplizumab, Stelo, and Inhaled Insulin Afrezza for Pediatric Patients	HCPLive @hcplivenews	53	Estados Unidos	88
13	Converting Basal Insulin Patients to Insulin Icodec	HCPLive @hcplivenews	49	Estados Unidos	87
7	Continuous Ketone Monitoring May Guide SGLT2i Use in T1D	HCPLive @hcplivenews	33	Estados Unidos	88
18	Alternative Endpoints for and Approaches to Metabolic Health, With Daria Igudesman, PhD, MS	HCPLive @hcplivenews	5	Estados Unidos	87